Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23321977 | 0.94 | CES2 (0.37) | CES2 | |
| SCHEMBL23321707 | 0.93 | CES2 (0.40) | CES2 | |
| SCHEMBL23321895 | 0.93 | CES2 (0.40) | CES2 | |
| SCHEMBL23322276 | 0.93 | CES2 (0.40) | CES2 | |
| SCHEMBL23321593 | 0.93 | CES2 (0.40) | CES2 | |
| SCHEMBL23321738 | 0.93 | CES2 (0.40) | CES2 | |
| SCHEMBL23321872 | 0.93 | CES2 (0.40) | CES2 | |
| SCHEMBL23321668 | 0.93 | CES2 (0.40) | CES2 | |
| SCHEMBL23321720 | 0.93 | CES2 (0.40) | CES2 | |
| SCHEMBL23321748 | 0.93 | CES2 (0.40) | CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2011834-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2012-07-25 | — | — | EP | claimed |
| US-11377455-B2 | Preparation of organosilicon compound having (meth)acryloyloxy group | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-07-05 | — | — | US | disclosed |
| US-20210139515-A1 | Preparation of Organosilicon Compound Having (Meth)acryloyloxy Group | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-05-13 | — | — | US | disclosed |
| EP-3819301-A1 | PREPARATION OF ORGANOSILICON COMPOUND HAVING (METH)ACRYLOYLOXY GROUP | Shin-Etsu Chemical Co., Ltd. (JP) | 2021-05-12 | — | — | EP | disclosed |
| CN-105392845-B | Photocurable composition | 思美定株式会社 | 2020-10-20 | — | — | CN | disclosed |
| EP-3081612-B1 | PHOTOCURABLE COMPOSITION HAVING ADHESIVE PROPERTIES | CEMEDINE CO LTD (JP) | 2018-11-14 | — | — | EP | disclosed |
| US-9718999-B2 | Photocurable composition having adhesive properties | CEMEDINE CO., LTD (JP) | 2017-08-01 | — | — | US | disclosed |
| US-20160312089-A1 | PHOTOCURABLE COMPOSITION HAVING ADHESIVE PROPERTIES | CEMEDINE CO., LTD. (JP) | 2016-10-27 | — | — | US | disclosed |
| EP-3081612-A1 | PHOTOCURABLE COMPOSITION HAVING ADHESIVE PROPERTIES | Cemedine Co., Ltd. (JP) | 2016-10-19 | — | — | EP | disclosed |
| US-20160152783-A1 | PHOTOCURABLE COMPOSITION | CEMEDINE CO., LTD. (JP) | 2016-06-02 | — | — | US | disclosed |
| EP-3023462-A1 | PHOTOCURABLE COMPOSITION | Cemedine Co., Ltd. (JP) | 2016-05-25 | — | — | EP | disclosed |
| EP-2011834-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-7772332-B2 | organotin-free catalyst; fluorosilane catalyst and an amine or aminoalkylsiloxane coupler used together for high curing of a polymer with a reactive silicon group; polymer is hydrosilylated polyether, polyisobutylene, or polyacrylate; sealant, adhesive; oil resistance; elasticity | KANEKA CORPORATION (JP) | 2010-08-10 | — | — | US | disclosed |
| US-20090069505-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2009-03-12 | — | — | US | disclosed |
| EP-2011834-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11377455-B2 | Preparation of organosilicon compound having (meth)acryloyloxy group | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, MMAB, ACR | CES2 792/4885 |
| US-20210139515-A1 | Preparation of Organosilicon Compound Having (Meth)acryloyloxy Group | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, MMAB, ACR | CES2 774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.